A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Medication Abortion: Senate Support for Mifepristone Safety
This resolution is currently in the Senate Committee on Health, Education, Labor, and Pensions for review. It has not been scheduled for any further action at this time. The bill is considered stalled as it waits for the committee to decide on its next steps.
Legislative Progress
While it has many supporters, abortion is a very divided issue in the Senate. It may be difficult to get the 60 votes needed to pass it if there is a debate.
Key Points
- This resolution states that the Senate believes mifepristone is a safe and effective medication. It points to 25 years of medical data and hundreds of studies showing the drug has very few risks.
- The proposal argues that the FDA should have the final say on drug safety. It says that judges or politicians should not interfere with scientific decisions about which medicines Americans can use.
- It highlights that medication abortion made up 63 percent of all abortions in 2023. The resolution supports keeping the drug available through the mail and telehealth to help people who live far from a doctor.
- The resolution specifically mentions that blocking this medicine hurts certain groups more than others. This includes people with low incomes, those living in rural areas, and people of color who already face hurdles in getting healthcare.
Impact Analysis
Govbase has not yet run an impact analysis on this legislation.
Milestones
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S2309-2310)
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Submitted in Senate
Votes
No votes have been recorded for this legislation yet.
News
No related news coverage found for this legislation yet.
Source Information
Document Type
Congressional Bill
Official Title
A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Data Sources
Sponsor
Cosponsors
(46)Analysis generated by AI. Always verify with official sources.